Status | Study |
Completed |
Study Name: Azilect + Antidepressant Chart Review Condition: Serotonin Syndrome Date: 2009-08-06 Interventions: Drug: Group R+AD Rasagiline + Antidepressant |
Terminated |
Study Name: Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2009-04-20 Interventions: Drug: Octreotide short acting octreotide |
Completed |
Study Name: Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy Condition: Carcinoid Syndrome Date: 2009-02-25 Interventions: Drug: Low Dose LX1606 Part 1 A |
Completed |
Study Name: An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2008-10-15 Interventions: Drug: Lanreotide deep s.c. inj |
Completed |
Study Name: Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor Condition: Carcinoid Tumor Malignant Carcinoid Syndrome Date: 2006-12-13 Interventions: Drug: Octreotide Octreotide 30 |
Withdrawn |
Study Name: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Carcinoma Date: 2005-09-26 Interventions: Drug: octreotide acetate Drug: vatalanib |
Terminated |
Study Name: Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome Condition: Malignant Carcinoid Syndrome Date: 2004-09-22 Interventions: Drug: lanreotide Autogel (somatostatin analogue) |
Completed |
Study Name: Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors Condition: Carcinoid Tumors Date: 2004-07-30 Interventions: Drug: Pasireotide (SOM230) Open label. Patients received starting dose of 300 µg of study drug subc |
Completed |
Study Name: Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors Condition: Metastatic Gastrointestinal Carcinoid Tumor Recurrent Gastrointestinal Carcinoid Tumor Date: 2003-03-06 Interventions: Biological: PEG-interferon alfa-2b |
Completed |
Study Name: Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors Condition: Gastrointestinal Carcinoid Tumor Lung Cancer Date: 1999-11-01 Interventions: Biological: recombinant interferon alfa Dr |